Aortic endovascular repair
Strength in evidence.
The proof is in the results.
You’re commited in durable outcomes for your patients. So are we. Medtronic maintains the longest-term aortic clinical evidence in the industry. We are invested in building the strength of aortic evidence that answers key clinical questions and elevates the standard of care.
Invested in building long-term clinical evidence
Medtronic maintains the longest-term clinical evidence in the industry, consistently showing successful clinical outcomes across different patient anatomies and the entire aortic portfolio.
- Unparalleled rigorous data collection process
- Medtronic ENGAGE OUS global patient registry with over 1,200 real-world participants and longest published evidence
- 400+ peer-reviewed publications on the Valiant™ Captivia™ thoracic stent graft system
- Demonstrated outcomes through five years in all DTA pathologies
- ANCHOR Registry five-year results on the Heli-FX™ EndoAnchor™ system
We are continuing to build our body of evidence by investing in randomized controlled trials (RCTs).
Endurant stent graft system — the standard of EVAR durability with 10-year data
As the first and only EVAR (endovascular aortic repair) system with a decade of global registry outcomes, Endurant™ systems continue to prove durability and strength in evidence with consistently high sac regression and low aneurysm-related mortality (ARM).2
Choose the standard of EVAR durability.
Proven durability with ESAR
EndoSuture aneurysm repair (ESAR) with the Heli-FX™ EndoAnchor™ system continues to demonstrate durable results in challenging patient with low type Ia endoleaks, low reinterventions, and positive sac regression rates.1
EndurantTM II/IIs stent graft system + RadiantTM balloon-expandable covered stent – Indicated. Tested. Proven in EnchEVAR.
Endurant™ II/IIs system + Radiant™ stent offers the only on-label and CE marked solution for ChEVAR. Indicated for patients with ≥ 2 mm neck length and ≤ 60° infrarenal angle. EnchEVAR, elevating ChEVAR therapy.
ValiantTM Captivia™ Stent Graft for TEVAR backed by five-years outcomes in all DTA pathologies
Valiant™ Captivia™ system provides consistent clinical performance across a variety of pathologies and five-year outcomes in all descending thoracic aortic (DTA) pathologies.
Related products and procedures
Medtronic Academy
Access interactive courses, case studies, presentations, and videos from your phone, tablet, or desktop.
Stay connected
Sign up for upcoming aortic events, training opportunities, and updates.
References
1
Jordan WD, Jr. New Developments from the ANCHOR Registry: Early 5 Year Prophylactic Results. Presented at VEITH Symposium 2021; Orlando, Florida.
2
Verhagen H, et al. The ENGAGE Registry: Ten-Year Outcomes with the Endurant Stent Graft for Endovascular Abdominal Aortic Aneurysm Repair. Presented at: Charing Cross 2023 International Symposium; April 26, 2023; London, UK.